Qiran Zhang

1.2k total citations
26 papers, 245 citations indexed

About

Qiran Zhang is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Qiran Zhang has authored 26 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Infectious Diseases and 7 papers in Hepatology. Recurrent topics in Qiran Zhang's work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (6 papers) and Hepatitis B Virus Studies (6 papers). Qiran Zhang is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (6 papers) and Hepatitis B Virus Studies (6 papers). Qiran Zhang collaborates with scholars based in China, Japan and South Korea. Qiran Zhang's co-authors include Chengdi Wang, H. C. Zhang, Wenhong Zhang, Jingwei Li, Lingyun Shao, Feng Sun, Xian Zhou, Jun Shao, Bin Xu and Jingwen Ai and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Qiran Zhang

22 papers receiving 241 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiran Zhang China 9 115 49 46 41 37 26 245
Zhou Zhou China 7 149 1.3× 60 1.2× 48 1.0× 59 1.4× 39 1.1× 14 318
Steve Anderson United States 7 161 1.4× 18 0.4× 69 1.5× 28 0.7× 54 1.5× 13 322
Lanlan Wei China 7 135 1.2× 42 0.9× 58 1.3× 42 1.0× 35 0.9× 16 253
Mona Sadeghalvad Iran 10 93 0.8× 38 0.8× 86 1.9× 62 1.5× 66 1.8× 19 319
Eleonora Tartaglia Italy 9 130 1.1× 46 0.9× 62 1.3× 37 0.9× 16 0.4× 18 253
Fu Li China 6 114 1.0× 16 0.3× 29 0.6× 35 0.9× 20 0.5× 18 227
Xianghua Guo China 11 394 3.4× 144 2.9× 120 2.6× 79 1.9× 77 2.1× 24 635
Fatima Barmania South Africa 4 192 1.7× 27 0.6× 67 1.5× 26 0.6× 34 0.9× 5 298
Amber Cornelius United States 11 178 1.5× 13 0.3× 87 1.9× 28 0.7× 14 0.4× 15 304
Mohamed Yaseen Alsabbagh Iran 4 138 1.2× 63 1.3× 40 0.9× 36 0.9× 28 0.8× 6 285

Countries citing papers authored by Qiran Zhang

Since Specialization
Citations

This map shows the geographic impact of Qiran Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiran Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiran Zhang more than expected).

Fields of papers citing papers by Qiran Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiran Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiran Zhang. The network helps show where Qiran Zhang may publish in the future.

Co-authorship network of co-authors of Qiran Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Qiran Zhang. A scholar is included among the top collaborators of Qiran Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiran Zhang. Qiran Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Qiran, et al.. (2025). Associations between disease acceptance and dietary adherence in patients with type 2 diabetes mellitus in China: a cross-sectional study. Diabetes Research and Clinical Practice. 224. 112196–112196.
2.
Chen, Sifan, Yuxuan Zhu, Qiran Zhang, et al.. (2025). A RISC-V 32-bit microprocessor based on two-dimensional semiconductors. Nature. 640(8059). 654–661. 18 indexed citations
3.
Li, Dan Dan, Hongyu Wang, Qiran Zhang, et al.. (2024). Clinical Characteristics, Treatment, and Prognosis of Osteoarticular Brucellosis: A Retrospective Real-World Study in Shenyang, China, 2014–2019. Foodborne Pathogens and Disease. 22(2). 86–96.
4.
Kong, Nan, Qiran Zhang, Xiaohong Gao, et al.. (2024). Predictive model for HBsAg clearance rate in chronic hepatitis B patients treated with pegylated interferon α-2b for 48 weeks. Hepatology International. 19(2). 358–367. 1 indexed citations
5.
Zhang, Yi, Zhangfan Fu, H. C. Zhang, et al.. (2024). Proteomic and Cellular Characterization of Omicron Breakthrough Infections and a Third Homologous or Heterologous Boosting Vaccination in a Longitudinal Cohort. Molecular & Cellular Proteomics. 23(6). 100769–100769. 1 indexed citations
6.
Li, Yina, et al.. (2023). Establishment of Bactrian Camel Induced Pluripotent Stem Cells and Prediction of Their Unique Pluripotency Genes. International Journal of Molecular Sciences. 24(3). 1917–1917. 5 indexed citations
7.
Zhang, Hanyue, Qiran Zhang, Yiqi Yu, et al.. (2023). Visualizing in situ viral replication across the natural history of chronic HBV infection. Hepatology Communications. 7(4). 1 indexed citations
8.
Feng, Jiaming, Qiran Zhang, Yazhou He, et al.. (2023). Epigenetic regulation of stem cells in lung cancer oncogenesis and therapy resistance. Frontiers in Genetics. 14. 1120815–1120815. 9 indexed citations
9.
Zhang, Yi, Yang Zhou, Jiazhen Chen, et al.. (2023). Vaccination Shapes Within-Host SARS-CoV-2 Diversity of Omicron BA.2.2 Breakthrough Infection. The Journal of Infectious Diseases. 229(6). 1711–1721. 1 indexed citations
10.
Zhang, Hanyue, Jianming Zheng, Chuan Shen, et al.. (2022). Evidence of Residual Ongoing Viral Replication in Chronic Hepatitis B Patients Successfully Treated With Nucleos(t)ide Analogues. The Journal of Infectious Diseases. 227(5). 675–685. 7 indexed citations
11.
12.
Li, Jingwei, Peiyi Li, Jun Shao, et al.. (2022). Emerging Role of Noncoding RNAs in EGFR TKI-Resistant Lung Cancer. Cancers. 14(18). 4423–4423. 10 indexed citations
13.
Ai, Jingwen, Yi Zhang, H. C. Zhang, et al.. (2022). Safety and immunogenicity of a third-dose homologous BBIBP-CorV boosting vaccination: interim results from a prospective open-label study. Emerging Microbes & Infections. 11(1). 639–647. 29 indexed citations
14.
Li, Jingwei, et al.. (2022). CircRNAs in lung cancer- role and clinical application. Cancer Letters. 544. 215810–215810. 20 indexed citations
15.
Qiu, Rong, Jingwei Li, Yuxuan Xiao, et al.. (2021). The therapeutic effect and safety of the drugs for COVID-19. Medicine. 100(16). e25532–e25532. 3 indexed citations
16.
Li, Jingwei, Qiran Zhang, Jun Shao, et al.. (2021). Artificial intelligence-assisted decision making for prognosis and drug efficacy prediction in lung cancer patients: a narrative review. Journal of Thoracic Disease. 13(12). 7021–7033. 22 indexed citations
17.
Wang, Chengdi, Jingwei Li, Qiran Zhang, et al.. (2021). The landscape of immune checkpoint inhibitor therapy in advanced lung cancer. BMC Cancer. 21(1). 968–968. 16 indexed citations
18.
Wang, Jie, Yiqi Yu, Chao Qiu, et al.. (2020). Maternal antiviral treatment safeguards infants from hepatitis B transmission in contingencies of delayed immunoprophylaxis. Liver International. 40(10). 2377–2384. 2 indexed citations
19.
Shi, Jichan, Yang Li, Xian Zhou, et al.. (2020). Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study. BMC Medicine. 18(1). 168–168. 59 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhou Zhou Breakdown of academic impact, for papers by Steve Anderson Breakdown of academic impact, for papers by Lanlan Wei Breakdown of academic impact, for papers by Mona Sadeghalvad Breakdown of academic impact, for papers by Eleonora Tartaglia Breakdown of academic impact, for papers by Fu Li Breakdown of academic impact, for papers by Xianghua Guo Breakdown of academic impact, for papers by Fatima Barmania Breakdown of academic impact, for papers by Amber Cornelius Breakdown of academic impact, for papers by Mohamed Yaseen Alsabbagh
Rankless by CCL
2026